Sinocare Inc. (SHE:300298)

Market Cap	12.10B
Revenue (ttm)	4.44B
Net Income (ttm)	326.29M
Shares Out	553.84M
EPS (ttm)	0.59
PE Ratio	37.10
Forward PE	27.95
Dividend	0.22 (1.01%)
Ex-Dividend Date	Jun 17, 2024

Volume	4,680,900
Average Volume	6,824,101
Open	21.97
Previous Close	21.85
Day's Range	21.40 - 22.02
52-Week Range	19.32 - 35.46
Beta	0.27
RSI	46.77
Earnings Date	Apr 21, 2025

About Sinocare

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It als...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 4,531
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300298

Financial Performance

In 2024, Sinocare's revenue was 4.44 billion, an increase of 9.47% compared to the previous year's 4.06 billion. Earnings were 326.29 million, an increase of 14.73%.